StockData
Adlai Nortye Group Ltd. logo

Adlai Nortye Group Ltd. (ANL) stock

ANLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 10, 2026Score 0/30
$10.03−0.58 (-5.47%)

Close on Nov 16, 2026Market cap $401.20MP/E –Yield –

Adlai Nortye ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2025 it was -$35.22M.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$35.22M–
FY2024Dec 31, 2024-$52.42M–
FY2023Dec 31, 2023-$72.09M–
FY2022Dec 31, 2022-$66.66M–

More Adlai Nortye figures

See a number that looks wrong?